PILON, CATIA
 Distribuzione geografica
Continente #
NA - Nord America 1.347
AS - Asia 167
EU - Europa 152
OC - Oceania 2
Totale 1.668
Nazione #
US - Stati Uniti d'America 1.346
CN - Cina 88
SG - Singapore 70
IT - Italia 41
DE - Germania 25
FI - Finlandia 25
UA - Ucraina 18
FR - Francia 15
SE - Svezia 14
GB - Regno Unito 12
VN - Vietnam 5
AU - Australia 2
IN - India 2
BE - Belgio 1
CA - Canada 1
ID - Indonesia 1
JP - Giappone 1
NO - Norvegia 1
Totale 1.668
Città #
Fairfield 212
Woodbridge 140
Houston 130
Ann Arbor 104
Jacksonville 86
Chandler 83
Cambridge 74
Seattle 66
Wilmington 66
Singapore 60
Ashburn 58
Santa Clara 49
Princeton 28
Padova 27
Boardman 22
San Diego 21
Beijing 15
Nanjing 14
Roxbury 13
Des Moines 11
Helsinki 9
Medford 9
Nanchang 6
Dong Ket 5
Shenyang 5
London 4
Norwalk 4
Hanover 3
Hebei 3
Jiaxing 3
Jinan 3
Milan 3
Changsha 2
Guangzhou 2
Hefei 2
Kharkiv 2
Paris 2
Phoenix 2
Redwood City 2
Veroli 2
Baotou 1
Borås 1
Cavarzere 1
Fuzhou 1
Gallipolis 1
Kunming 1
Lanzhou 1
Las Vegas 1
Munich 1
Nanning 1
Ogden 1
Orange 1
Oslo 1
Pune 1
Rende 1
Semarang 1
Shanghai 1
Southwark 1
Squamish 1
Tappahannock 1
Wandsworth 1
Wuhan 1
Totale 1.374
Nome #
Effects of Taxol on the human NCI-H295 adrenocortical carcinoma cell line. 128
The role of 21-hydroxylase in the pathogenesis of adrenal masses: Review of the literature and focus on our own experience 127
Insulin signaling in adipose tissue of patients with primary aldosteronism 124
Analysis of Insulin Sensitivity in Adipose Tissue of Patients with Primary Aldosteronism 109
Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism 106
Isolated R171Q amino acid change in MEN1 gene: polymorphism or mutation? 97
Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series 92
Retention of heterozygosity at chromosome 7p22 and 11q13 in aldosterone-producing tumours of patients with familial hyperaldosteronism not remediable by glucocorticoids 90
Retention of heterozygosity at chromosome 7p22 and 11q13 in aldosterone-producing tumors of patients with familial hyperaldosteronism not remediable by glucocorticoids 88
Genetic studies in familial aldosteronism not suppressible by dexamethasone 83
Primary aldosteronism and metabolic syndrome. 83
null 82
CYP11B2 gene polymorphisms in idiopathic hyperaldosteronism. 80
Statins reduce intratumor cholesterol affecting adrenocortical cancer growth 72
Role of Scaffold Protein Proline-, Glutamic Acid-, and Leucine-Rich Protein 1 (PELP1) in the Modulation of Adrenocortical Cancer Cell Growth 69
1?,25-Dihydroxyvitamin D3 inhibits the human H295R cell proliferation by cell cycle arrest: A model for a protective role of vitamin D receptor against adrenocortical cancer. 66
Targeting Estrogen Receptor-  Reduces Adrenocortical Cancer (ACC) Cell Growth in Vitro and in Vivo: Potential Therapeutic Role of Selective Estrogen Receptor Modulators (SERMs) for ACC Treatment 62
DNA methylation of steroidogenic enzymes in benign adrenocortical tumors: New insights in aldosterone-producing adenomas 55
Diagnosi molecolare della neoplasia endocrina multipla tipo 2 43
Methylation status of Vitamin D receptor gene promoter in benign and malignant adrenal tumors 29
Totale 1.685
Categoria #
all - tutte 5.937
article - articoli 5.780
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.717


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020200 0 0 0 0 0 25 25 50 34 29 21 16
2020/2021225 9 17 3 17 11 24 12 23 41 18 23 27
2021/2022258 5 38 31 7 16 20 15 25 10 11 34 46
2022/2023197 37 7 3 17 36 24 0 14 37 2 10 10
2023/202473 6 21 11 8 3 1 0 3 1 0 8 11
2024/2025190 1 55 15 23 76 20 0 0 0 0 0 0
Totale 1.685